PL1937212T3 - Emulsje oftalmiczne zawierające prostaglandyny - Google Patents

Emulsje oftalmiczne zawierające prostaglandyny

Info

Publication number
PL1937212T3
PL1937212T3 PL06806156T PL06806156T PL1937212T3 PL 1937212 T3 PL1937212 T3 PL 1937212T3 PL 06806156 T PL06806156 T PL 06806156T PL 06806156 T PL06806156 T PL 06806156T PL 1937212 T3 PL1937212 T3 PL 1937212T3
Authority
PL
Poland
Prior art keywords
sub
emulsions containing
prostaglandins
emulsions
oily core
Prior art date
Application number
PL06806156T
Other languages
English (en)
Inventor
Betty Philips
Séverine Bague
Laura Rabinovich-Guilatt
Grégory Lambert
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/011648 external-priority patent/WO2006050836A2/en
Application filed by Santen Sas filed Critical Santen Sas
Publication of PL1937212T3 publication Critical patent/PL1937212T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL06806156T 2005-10-10 2006-10-10 Emulsje oftalmiczne zawierające prostaglandyny PL1937212T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2005/011648 WO2006050836A2 (en) 2004-11-09 2005-10-10 Ophthalmic emulsions containing prostaglandins
PCT/EP2006/009783 WO2007042262A2 (en) 2005-10-10 2006-10-10 Ophthalmic emulsions containing prostaglandins
EP06806156A EP1937212B1 (en) 2005-10-10 2006-10-10 Ophthalmic emulsions containing prostaglandins

Publications (1)

Publication Number Publication Date
PL1937212T3 true PL1937212T3 (pl) 2011-02-28

Family

ID=37600871

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06806156T PL1937212T3 (pl) 2005-10-10 2006-10-10 Emulsje oftalmiczne zawierające prostaglandyny

Country Status (13)

Country Link
EP (1) EP1937212B1 (pl)
JP (1) JP5247453B2 (pl)
KR (1) KR101286807B1 (pl)
CN (1) CN101282714B (pl)
AT (1) ATE479424T1 (pl)
AU (1) AU2006301493B2 (pl)
CA (1) CA2625568C (pl)
DE (1) DE602006016628D1 (pl)
DK (1) DK1937212T3 (pl)
ES (1) ES2351358T3 (pl)
PL (1) PL1937212T3 (pl)
PT (1) PT1937212E (pl)
WO (1) WO2007042262A2 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985298A1 (en) 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
CA2730221C (en) * 2007-07-09 2016-02-02 Novagali Pharma Sa Oil in water emulsion comprising nsaids and quaternary ammonium halides
US8512687B2 (en) 2007-07-09 2013-08-20 Novagali Pharma Sa Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
ES2352296T3 (es) * 2007-07-09 2011-02-17 Novagali Pharma S.A. Emulsión de aceite en agua que comprende aine y haluros de amonio cuaternarios.
EP2044951A1 (en) * 2007-10-02 2009-04-08 Merz Pharma GmbH & Co. KGaA The use of substances for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
EP2229174A1 (en) * 2007-12-04 2010-09-22 Novagali Pharma S.A. Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
EP2228058A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2228057A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
US8501800B2 (en) * 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
CA2773597A1 (en) * 2009-09-17 2011-03-24 Senju Pharmaceutical Co., Ltd. Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
HUE059325T2 (hu) * 2010-07-29 2022-11-28 Allergan Inc Tartósítószer-mentes bimatoprost és timolol oldatok
US20130065888A1 (en) * 2011-08-15 2013-03-14 Biserka Cetina-Cizmek Ophthalmic formulations and processes for their preparation
EP2567689A1 (en) 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
WO2013052380A2 (en) * 2011-10-05 2013-04-11 Allergan, Inc. Compositions for enhancing nail health
KR102433489B1 (ko) * 2013-03-14 2022-08-17 팬옵티카, 인크. 눈의 후안부로의 약물 전달을 위한 안구용 제제
KR20150000405A (ko) * 2013-06-24 2015-01-02 한국콜마주식회사 난용성 의약품의 수중유적형 에멀젼 조성물 및 이의 제조방법
WO2014207769A1 (en) 2013-06-27 2014-12-31 Mylan Laboratories Ltd Process for the preparation of nepafenac
WO2016013993A1 (en) 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
JP6404785B2 (ja) * 2015-08-12 2018-10-17 日本電信電話株式会社 生体分子移動度制御方法および電気泳動槽
CN109498597B (zh) * 2018-12-07 2021-12-14 佛山市正典生物技术有限公司 一种喹烯酮微丸及其制备方法
JP6855026B1 (ja) * 2020-11-09 2021-04-07 東亜薬品株式会社 タフルプロスト点眼液
CN116725954B (zh) * 2023-07-12 2026-03-31 浙江大学 一种具有抗氧化功能的纳米制剂及治疗青光眼用途
EP4791355A1 (en) 2023-10-11 2026-08-19 Santen SAS Kit for stabilising prostaglandin emulsions
JP7799358B1 (ja) * 2025-06-27 2026-01-15 株式会社シンコーホールディングス Ｐｆａｓの処理方法およびフッ化カルシウムの製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JP2602964B2 (ja) * 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
EP1441696B1 (en) * 2001-11-01 2010-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and composition for dry eye treatment
KR100446960B1 (ko) * 2001-12-04 2004-09-01 김종국 프로스타글란딘 ｅ1을 포함하는 온도감응성 에멀젼 외용제조성물
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
DE602004023106D1 (de) 2003-11-07 2009-10-22 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin

Also Published As

Publication number Publication date
WO2007042262A8 (en) 2008-05-08
ATE479424T1 (de) 2010-09-15
CA2625568A1 (en) 2007-04-19
JP5247453B2 (ja) 2013-07-24
WO2007042262A3 (en) 2007-08-16
CN101282714B (zh) 2012-12-12
DK1937212T3 (da) 2010-12-13
CA2625568C (en) 2013-10-08
KR20080066675A (ko) 2008-07-16
ES2351358T3 (es) 2011-02-03
AU2006301493A1 (en) 2007-04-19
DE602006016628D1 (de) 2010-10-14
AU2006301493B2 (en) 2013-01-10
JP2009511442A (ja) 2009-03-19
WO2007042262A2 (en) 2007-04-19
EP1937212A2 (en) 2008-07-02
CN101282714A (zh) 2008-10-08
EP1937212B1 (en) 2010-09-01
PT1937212E (pt) 2010-11-30
KR101286807B1 (ko) 2013-07-23

Similar Documents

Publication Publication Date Title
WO2006050836A3 (en) Ophthalmic emulsions containing prostaglandins
DK1937212T3 (da) Oftalmiske emulsioner indeholdende prostaglandiner
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
MX2007005545A (es) Emulsion oftalmica tipo aceite en agua con potencial zeta positivo estable.
KR101702157B1 (ko) 안과용 조성물
RU2009143324A (ru) Офтальмические эмульсии масло-в-воде, содержащие простагландины
ES2194670T3 (es) Emulsiones especificas de glandula lagrimal para aplicacion topica al tejido ocular.
EP2197449A2 (en) Novel ophthalmic compositions
JP2010524992A5 (pl)
HRP20170769T1 (hr) Postupak i pripravak za liječenje očne hipertenzije i glaukoma
NZ560788A (en) Ophthalmic solution comprising bimatoprost and benzalkonium chloride
JP2013512917A (ja) 眼科用エマルジョン
MXPA96003560A (en) Compositions of stable prostaglandines enalmacenamie
CO5570649A2 (es) Producto antitranspirante en gel liquido de alta eficiencia
KR20110005801A (ko) 바람직한 생체이용률을 갖는 약제학적 조성물
FR3108843B1 (fr) Composition cosmétique pour soin de la peau
JP2014515383A5 (pl)
JP4072119B2 (ja) 安定化された透明な香料エマルション
JP2001187733A5 (pl)
WO2007059888A3 (en) Oil-in-water emulsions based on special emulsifiers
RU2009120545A (ru) Модуляторы связывания pai-1 для лечения глазных болезней
DE602006001226D1 (de) Schäumende O/W-Emulsion und ihre Verwendung in der Kosmetik
FR3130600B1 (fr) Composition aqueuse parfumée comprenant au moins deux tensioactifs, au moins une substance parfumante et au moins un diol
JPWO2006009101A1 (ja) コンタクトレンズ用装着液
DK3107906T3 (en) REDUCED CENTRAL CORNER MAP THICKNESS USING HYDROFILE ESTER PRODRUGS OF BETA-CHLORCYCLOPENTANE